GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » QLY Biotech Group Corp (OTCPK:LQLY) » Definitions » Net Income From Continuing Operations

QLY Biotech Group (QLY Biotech Group) Net Income From Continuing Operations : $-0.03 Mil (TTM As of Feb. 2023)


View and export this data going back to 2021. Start your Free Trial

What is QLY Biotech Group Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. QLY Biotech Group's net income from continuing operations for the three months ended in Feb. 2023 was $-0.01 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Feb. 2023 was $-0.03 Mil.

QLY Biotech Group Net Income From Continuing Operations Historical Data

The historical data trend for QLY Biotech Group's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QLY Biotech Group Net Income From Continuing Operations Chart

QLY Biotech Group Annual Data
Trend Aug19 Aug20 Aug21 Aug22
Net Income From Continuing Operations
- -0.01 -0.03 -0.01

QLY Biotech Group Quarterly Data
Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -0.01 -0.01 -0.01

QLY Biotech Group Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Feb. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QLY Biotech Group (QLY Biotech Group) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » QLY Biotech Group Corp (OTCPK:LQLY) » Definitions » Net Income From Continuing Operations
Comparable Companies
ONVC ARMV NNAX ISPO BKNG ABNB XMAD:AMS TCOM RCL CCL EXPE NCLH HKSE:00780 MMYT XPAR:MMB LSE:JET2 ASX:FLT TNL TRIP SAU:1810
Traded in Other Exchanges
N/A
Address
5348 Vegas Drive, Las Vegas, NV, USA, 89108
Website
QLY Biotech Group Corp is a United States based company engaged in the tourism business.

QLY Biotech Group (QLY Biotech Group) Headlines

No Headlines